We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Axcella Health Inc | NASDAQ:AXLA | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 4.58 | 4.50 | 4.51 | 0 | 01:00:00 |
Axcella (Nasdaq: AXLA) is a clinical-stage biotechnology company focused on leveraging endogenous metabolic modulators (EMMs) to pioneer a new approach for treating complex diseases and improving health. The company’s product candidates are comprised of EMMs and their derivatives that are engineered in distinct combinations and ratios to simultaneously impact multiple biological pathways. Axcella’s pipeline includes lead therapeutic candidates for non-alcoholic steatohepatitis (NASH) and the reduction in risk of overt hepatic encephalopathy (OHE) recurrence. Additional muscle- and blood-related programs are in earlier-stage development. For more information, please visit www.axcellahealth.com.
Company:
Axcella Health Inc.
Headquarters Address:
840 Memorial Dr., Third Floor
CAMBRIDGE, MA 02139
Main Telephone:
857-320-2200
Website:
www.axcellahealth.com
Ticker:
AXLA(NASDAQ)
Type of Organization:
Public
Industry:
Biotechnology
Key Executives:
CEO: Bill Hinshaw
Investor Relations
Contact:
Jason Fredette
Phone:
7814240946
Email:
jfredette@axcellahealth.com
View source version on businesswire.com: https://www.businesswire.com/news/home/20200924005860/en/
1 Year Axcella Health Chart |
1 Month Axcella Health Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions